EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Myt1 kinase inhibitors - Insight into structural features, offering potential frameworks

Katarina Tomović Pavlović, Gordana Kocić, Andrija Šmelcerović

Chemico-Biological Interactions · 2024

DOI: 10.1016/j.cbi.2024.110901 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemico-Biological Interactions, 2024. Verfasst von Katarina Tomović Pavlović und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Medicine, University of Niš, Bulevar Dr Zorana Đinđića 81, 18000, Niš, Serbia. Electronic address: katarinat91@gma…. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Republic of Serbia Ministry of Education Science and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cell cycle includes two checkpoint arrests allowing to repair of damaged DNA. Many cancer cell lines exhibit weak G1 checkpoint mechanisms relying significantly more on the G2 checkpoint than do healthy cells. Inhibition of Myt1 kinase (PKMYT1), a forgotten member of the Wee family, cyclin-dependent kinase 1 (Cdk1) inhibitory kinase, target for G2 checkpoint abrogation, whose inhibition forces cells into premature unchecked mitosis resulting in cell death, is a promising concept for anticancer therapy. There are not many inhibitors of this emerging, potentially clinically important kinase. Herein, the valuable insight into structural features and binding mechanisms of diaminopyrimidines, aminoquinolines, quinazolines, pyrido[2,3-d]pyrimidines, pyrazolo[3,4-d]pyrimidines, and pyrrolo[2,3-b]quinoxalines, as well as finally made a general scheme of fragmented structures of Myt1 inhibitors with the enzyme, offer potential frameworks useful for future directions, for further chemical optimizations, in the discovery and the design of novel effective structures, potential therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Cycle ProteinsNeoplasmsHumansCDC2 Protein KinaseMitosisG2 Phase Cell Cycle CheckpointsPyrimidinesPhosphorylationMembrane ProteinsProtein-Tyrosine KinasesProtein Serine-Threonine Kinases

Stichwörter der Autor:innen

Anticancer therapyG2 checkpointInhibitorProtein kinase Myt1Structural analysis

Substanzen

Cell Cycle ProteinsCDC2 Protein KinasePyrimidinesPKMYT1 protein, humanMembrane ProteinsProtein-Tyrosine KinasesProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Pharmacy, Faculty of Medicine, University of Niš, Bulevar Dr Zorana Đinđića 81, 18000, Niš, Serbia. Electronic address: katarinat91@gmail.com.
  • Department of Biochemistry, Faculty of Medicine, University of Niš, Bulevar Dr Zorana Đinđića 81, 18000, Niš, Serbia.
  • Department of Chemistry, Faculty of Medicine, University of Niš, Bulevar Dr Zorana Đinđića 81, 18000, Niš, Serbia. Electronic address: a.smelcerovic@yahoo.com.

Förderung

  • Republic of Serbia Ministry of Education Science and Technological Development

Zitieren

APA

Tomović Pavlović, K., Kocić, G., & Šmelcerović, A. (2024). Myt1 kinase inhibitors - Insight into structural features, offering potential frameworks. Chemico-Biological Interactions. https://doi.org/10.1016/j.cbi.2024.110901

Vancouver

Tomović Pavlović K, Kocić G, Šmelcerović A. Myt1 kinase inhibitors - Insight into structural features, offering potential frameworks. Chemico-Biological Interactions. 2024. doi:10.1016/j.cbi.2024.110901

BibTeX
@article{TomoviPavlovi2024,
  author = {Tomović Pavlović, Katarina and Kocić, Gordana and Šmelcerović, Andrija},
  title = {Myt1 kinase inhibitors - Insight into structural features, offering potential frameworks},
  journal = {Chemico-Biological Interactions},
  year = {2024},
  doi = {10.1016/j.cbi.2024.110901}
}
Kostenlos starten →